What is the recommended outpatient antibiotic regimen, including drug selection, dosage, and duration, for an otherwise healthy adult with acute bacterial sinusitis?

Adult Acute Bacterial Sinusitis: Outpatient Antibiotic Regimen

For otherwise healthy adults with acute bacterial sinusitis, prescribe amoxicillin with or without clavulanate for 5-10 days as first-line therapy, though watchful waiting for up to 7 days is equally appropriate if reliable follow-up is assured. 1, 2

First-Line Antibiotic Selection

Amoxicillin with or without clavulanate is the recommended first-line agent based on Grade A evidence from multiple systematic reviews of RCTs 1, 3. The 2025 AAO-HNS guideline specifically changed its recommendation from amoxicillin alone to amoxicillin with or without clavulanate 2. This provides optimal coverage against the most common pathogens (Streptococcus pneumoniae and Haemophilus influenzae) while minimizing broader-spectrum antibiotic use and resistance development.

Specific Dosing:

• Standard-dose amoxicillin: 500 mg three times daily OR 875 mg twice daily
• High-dose amoxicillin-clavulanate: 2000 mg/125 mg twice daily (extended-release) or 875 mg/125 mg twice daily
• High-dose formulations are preferred for patients with recent antibiotic use (within 4-6 weeks), moderate-to-severe disease, or regions with high resistance rates 4, 5

Important caveat: A 2018 RCT found that immediate-release high-dose amoxicillin-clavulanate (1750 mg twice daily) led to more rapid improvement at day 3 (52.4% vs 34.4%, p=0.04) but also significantly more severe diarrhea (15.8% vs 4.8%, p=0.048) 6. The extended-release formulation showed no benefit over standard dosing.

Treatment Duration

5-7 days is as effective as 10-14 days with fewer adverse effects 1, 7. The most recent 2025 guideline and 2015 AAO-HNS guideline both recommend 5-10 days 1, 2. A meta-analysis of 12 RCTs involving 4,430 patients demonstrated no difference in clinical success between short-course (3-7 days) and long-course (6-10 days) treatment, with fewer adverse events in the 5-day regimen group 7.

Practical recommendation: Start with 5-7 days for uncomplicated cases; reserve 10 days for patients with severe symptoms or complicating factors.

Alternative Regimens for Penicillin Allergy

• Doxycycline: 100 mg twice daily for 5-7 days 8, 9
• Respiratory fluoroquinolones (levofloxacin, moxifloxacin): Reserve as second-line or for patients with recent antibiotic use 4, 5
• Trimethoprim-sulfamethoxazole: Alternative for mild disease in adults 4
• Cephalosporins (cefuroxime, cefpodoxime, cefdinir): For non-type I hypersensitivity 4

Critical point: Macrolides (azithromycin, clarithromycin) have poor activity against penicillin-resistant S. pneumoniae and H. influenzae and should generally be avoided 4.

Watchful Waiting as Initial Strategy

Watchful waiting without immediate antibiotics is appropriate for ALL patients with uncomplicated ABRS, regardless of severity 1, 2. This represents a significant change from the 2015 guideline, which limited this approach to "mild" illness. The 2025 guideline extends this to all severity levels.

Implementation:

• Provide a prescription but instruct patients to fill it only if:
  • No improvement after 7 days, OR
  • Worsening at any time
• This approach is supported by Grade A evidence showing most patients improve spontaneously, with antibiotics providing only modest benefit (NNT 10-15 for symptom relief at 7-15 days) 1

Rationale:

• Reduces antibiotic-related adverse events (NNH 8.1) 3
• Decreases antimicrobial resistance
• Most patients improve naturally within 7-15 days 1

When to Reassess and Change Therapy

Reassess at 3-5 days for severe symptoms or at 7 days for lack of improvement 4, 1, 2:

• If no improvement by 7 days: Start antibiotics if initially managed with watchful waiting, or switch antibiotics if already on treatment
• If worsening at any time: Reassess to confirm ABRS, exclude complications, and initiate or change antibiotic therapy

Second-line options for treatment failure:

• High-dose amoxicillin-clavulanate (if not already used)
• Respiratory fluoroquinolones (levofloxacin, moxifloxacin)
• Cephalosporins (cefuroxime, cefpodoxime, cefdinir) 4, 1

Adjunctive Symptomatic Management

While antibiotics address bacterial infection, symptomatic relief is important:

• Saline nasal irrigation: Effective and safe 1
• Analgesics: Acetaminophen or ibuprofen for pain/fever 1
• Nasal corticosteroid sprays: Small benefit after 15 days (NNT 14), with side effects including headache and epistaxis 1
• Decongestants: May provide temporary relief; limit topical use to ≤3 days to avoid rebound congestion 1

Avoid routinely: Antihistamines and oral corticosteroids lack evidence for benefit in acute bacterial sinusitis 1, 4

Common Pitfalls to Avoid

1. Overprescribing antibiotics: Recent data shows antibiotics are prescribed in 80% of encounters that don't meet criteria for bacterial sinusitis 10. Most acute rhinosinusitis is viral and self-limited.

2. Using broad-spectrum agents first-line: Reserve fluoroquinolones and third-generation cephalosporins for treatment failure or specific indications to minimize resistance 1, 2.

3. Excessive treatment duration: The 2020 EPOS guideline and multiple meta-analyses confirm no benefit beyond 5-7 days for uncomplicated cases 11, 7, 12.

4. Ignoring local resistance patterns: In areas with high penicillin-resistant S. pneumoniae, consider high-dose amoxicillin-clavulanate as first-line 4, 5.

5. Treating post-viral rhinosinusitis with antibiotics: The 2020 EPOS guideline strongly advises against antibiotics for post-viral ARS in adults, showing no benefit and more adverse events 11.